Skip to main content
State Seal State Seal State Seal
Home Button Home Button Home Button

Rep. Lipps Announces Passage of Legislation to Help Curb Ohio's Opioid Crisis

Bill aims to limit unintended access to certain drugs
June 20, 2018
P. Scott Lipps News

COLUMBUS—State Representative Scott Lipps (R-Franklin) today announced that the Ohio House has passed House Bill 231, legislation sponsored by Reps. Tim Ginter (R-Salem) and Robert Sprague (R-Findlay) that would enact a pilot program in pharmacies for tamper-resistant containers.

House Bill 231 would require the State Board of Pharmacy—contingent upon an appropriation from the General Assembly—to administer a two-year pilot program that would dispense schedule II controlled substances in lockable or tamper-evident containers. Schedule II drugs include narcotics like oxycodone, hydrocodone, fentanyl, and more. The goal of the legislation is to cut down on misuse of prescription drugs by reducing the accessibility of the medications and the threat of theft.

“The opioid crisis has decimated families, taxed the resources of our first responders, and erased millions of dollars from our economy,” Lipps said. “House Bill 231 is one example of how we are going to attack this epidemic from every possible direction.”

The bill would also require the State Board of Pharmacy to reimburse pharmacies for the cost of participating in the program, which includes expenses related to the special packaging for eligible prescriptions.

House Bill 231 now awaits consideration by the Senate.